 |
Description of Individual Course Units| Course Unit Code | Course Unit Title | Type of Course Unit | Year of Study | Semester | Number of ECTS Credits | | EC201B | Practical Drug Information I | Compulsory | 2 | 3 | 5 |
| | Level of Course Unit | | Short Cycle | | Objectives of the Course | | The objective of this course is, to provide students to be able to interpret pharmacology and drugs; to express OTS and prescription drugs in Turkey; to interpret basic pharmacology subjects such as pharmacodynamics, pharmacokinetics, drug mechanism of actions, drug interactions, drug administration routes, pharmacogenetic and drug therapy; to classify antibiotics, antifungal and antiviral drugs; to define central nerve system (CNS) and disorders related to CNS; to classify general and local anaesthetic drugs, CNS stimulants, drugs that are used in pain and alcoholism; to interpret and classify antipsychotics, antiepileptic drugs, antidepressant drugs, sedative hypnotic drugs, anxiolytics and the drugs used in parkinson diseaseand dementia ¸to classify renal, gastrointestinal and respiratory system disorders and the drugs used in these disorders; to interpret tobacco harms and the treatment of tobacco use disorder. | | Name of Lecturer(s) | | Dr. Öğr. Üyesi Umut İrfan ÜÇEL | | Learning Outcomes | | 1 | To be able to interpret pharmacology and drug concepts | | 2 | Interpret pharmacodynamics, pharmacokinetics, pharmacogenetics, drug mechanism of actions, management of drug treatments, prescription and drug administration routes. | | 3 | Interpret basic principles of antibacterial therapy and classify antibiotics | | 4 | Classify antiviral and antifungal drugs. | | 5 | Interpret CNS and the disorders of CNS. |
| | Mode of Delivery | | Second Education | | Prerequisites and co-requisities | | None | | Recommended Optional Programme Components | | None | | Course Contents | | 1. Pharmacology and drugs, history of the drugs, drug marketing authorization in Turkey. 2. Pharmacodynamics, pharmacokinetics, mechanisms of basic drug interactions and drug mechanism of actions. 3. Pharmacogenomics and individualized therapy. 4. Management of drug therapy, drug administration routes and factors affecting drug actions. 5. Basic principles of antibacterial therapy and important antibacterial drugs. 6. Antiviral and antifungal drugs. 7. Basic principles of CNS. 8. General and local anaesthetic drugs 9. Pain and pain management ( Opioids). 10. Depression, psychosis, anxiety, sleep disorders, epilepsia, Parkinson and dementia and the drugs used in these disorders. 11. CNS stimulants. 12. Drugs that are used in alcoholism and tobacco harms and the treatment of tobacco use disorder. 13. Drugs used in respiratory system disorders 14. Drugs used in gastrointestinal system disorders. 15. Drugs used in renal system disorders. | | Weekly Detailed Course Contents | |
| 1 | • Pharmacology and drugs • Brief history of drugs • Drugs in Turkey: Prescription and nonprescription drugs Controlled drugs • Drug marketing authorization in Turkey | | | | 2 | • Pharmacodynamics, pharmacokinetics • Drug mechanism of actions • ADME • Pharmacogenomics and individualized therapy • Basic mechanisms of drug interactions | | | | 3 | • Prescription • Drug administration routes • Factors affecting drug actions. • Management of drug therapy. • Drug safety | | | | 4 | • General principles of antibacterial therapy • Enfections • Antibiotic spectrum • Important antibacterial drug groups • Sulfonamides • Penicillins • Cephalosporins • Tetrascyclines • Makrolides | | | | 5 | • Ketolides • Quinolones • Streptogramins • Aminoglycosides • Cyclic lipopeptides • Treatment of tuberculosis | | | | 6 | Ketolides • Quinolones • Streptogramins • Aminoglycosides • Cyclic lipopeptides • Treatment of tuberculosis II | | | | 7 | • Basic principles of CNS • General and local anaesthetic drugs • Pain and pain management ( Opioids) | | | | 8 | Midterm exam | | | | 9 | • Depression and antidepressant drugs • Psychosis and antipsychotics • Anxiety and anxiolytics • Sleep disorders and sedative hypnotic drugs • Alcoholism | | | | 10 | • Antiepileptic drugs • Parkinson Disease and drugs used in Parkinson Disease • Dementia and drugs used in dementia | | | | 11 | • Neuroleptic drugs • CNS stimulants • Drugs used in other CNS disorders | | | | 12 | • Respiratory system and treatment of respiratory system disorders • Drugs used in asthma • Drugs used in Chronic obstructive pulmonary disease | | | | 13 | • Systemic and local decongestants • Drugs used in other respiratory system disorders • Cough and antitussive drugs • Flu and allergy • Tobacco harms and the treatment of tobacco use disorder | | | | 14 | • Basic principles of gastrointestinal system disorders • Gastroesophageal reflux disease (GERD) and drugs used in GERD • Gastrointestinal ulcers and drugs used in ulcers | | | | 15 | • Diarrhea and antidiarrheal agents • Constipation and drugs used in constipation • Vomiting, emesis and antiemetic drugs • Obesity and treatment of obesity • Gi parasites and anthelmintic drugs • Hepatitis and drugs used in hepatitis | | |
| | Recommended or Required Reading | | 1. Lippincott Farmakoloji, Prof.Dr. Filiz Onat, Doç.Dr. Zafer Gören, Doç.Dr. Atila Karaalp, Nobel Yayınevi, 3. Baskı, ISBN : 9789754207149 2. Tıbbi Farmakoloji, Prof.Dr. S. Oğuz Kayaalp, Hacettepe Taş Yayınevi, 2005, ISBN : 9789759534158 3. Fundamental Pharmacology for Pharmacy Technicians, Jahangir Moini, Delmar Cengage learning, 2009, ISBN 10: 1-4180-5357-0 | | Planned Learning Activities and Teaching Methods | | | Assessment Methods and Criteria | |
| Midterm Examination | 1 | 100 | | SUM | 100 | |
| Final Examination | 1 | 100 | | SUM | 100 | | Term (or Year) Learning Activities | 40 | | End Of Term (or Year) Learning Activities | 60 | | SUM | 100 |
| | Language of Instruction | | Turkish | | Work Placement(s) | | None |
| | Workload Calculation | |
| Midterm Examination | 1 | 1 | 1 | | Final Examination | 1 | 2 | 2 | | Attending Lectures | 14 | 2 | 28 | | Question-Answer | 14 | 2 | 28 | | Individual Study for Mid term Examination | 7 | 4 | 28 | | Individual Study for Final Examination | 14 | 4 | 56 | |
| Contribution of Learning Outcomes to Programme Outcomes | | LO1 | 3 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | | LO2 | 3 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | | LO3 | 3 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | | LO4 | 3 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | | LO5 | 3 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| | * Contribution Level : 1 Very low 2 Low 3 Medium 4 High 5 Very High |
 |
| |
|
|